Literature DB >> 3310502

A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis.

H Kamo1, H Haebara, I Akiguchi, M Kameyama, H Kimura, P L McGeer.   

Abstract

Morphological changes in astrocytes have been studied in the primary motor cortex of persons dying with or without amyotrophic lateral sclerosis (ALS). Glial fibrillary acidic protein (GFAP) and S-100 protein were used as immunohistochemical markers for reactive astroglia. In 12 brains of individuals without neurological disease glial cells showing moderate immunoreactivity for both GFAP and S-100 protein were uniformly distributed in the primary motor cortex in the upper regions of layer I and layer II. In 8 of 11 ALS cases, intensely immunoreactive cells were additionally found to occur and were scattered irregularly, mostly in layers II and III, but occasionally in layers IV and V. Clusters of these intensely positive cells occurred in patches about 200-400 micron in diameter, each containing about 6 to greater than 20 such cells. GFAP-positive astrocytes were seen in some of the 36 brains from persons with neurological problems other than ALS but the pattern was different. The abnormal appearance of clusters of positive astrocytes of the primary motor cortex may be intimately associated with the ALS disease process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3310502     DOI: 10.1007/BF00688335

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  12 in total

1.  Amyotrophic lateral sclerosis.

Authors:  T LAWYER; M G NETSKY
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-02

2.  Amyotrophic lateral sclerosis with progressive dementia and with pathologic findigs of the Creutzfeldt-Jakob syndrome.

Authors:  N C MYRIANTHOPOULOS; J K SMITH
Journal:  Neurology       Date:  1962-09       Impact factor: 9.910

3.  Degeneration of the human Betz cell due to amyotrophic lateral sclerosis.

Authors:  R P Hammer; U Tomiyasu; A B Scheibel
Journal:  Exp Neurol       Date:  1979-02       Impact factor: 5.330

4.  Cell structure and function in the visual cortex of the cat.

Authors:  J P Kelly; D C Van Essen
Journal:  J Physiol       Date:  1974-05       Impact factor: 5.182

5.  Positron emission tomography and histopathology in Pick's disease.

Authors:  H Kamo; P L McGeer; R Harrop; E G McGeer; D B Calne; W R Martin; B D Pate
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

6.  The central cholinergic system studied by choline acetyltransferase immunohistochemistry in the cat.

Authors:  H Kimura; P L McGeer; J H Peng; E G McGeer
Journal:  J Comp Neurol       Date:  1981-08-01       Impact factor: 3.215

7.  Pathology of amyotrophic lateral sclerosis.

Authors:  J T Hughes
Journal:  Adv Neurol       Date:  1982

8.  Presenile dementia with motor neuron disease in Japan. A new entity?

Authors:  Y Mitsuyama; S Takamiya
Journal:  Arch Neurol       Date:  1979-09

9.  Regeneration and remyelination of Xenopus tadpole optic nerve fibres following transection or crush.

Authors:  P J Reier; H F Webster
Journal:  J Neurocytol       Date:  1974-11

10.  Classic amyotrophic lateral sclerosis with dementia.

Authors:  J Wikström; A Paetau; J Palo; R Sulkava; M Haltia
Journal:  Arch Neurol       Date:  1982-11
View more
  18 in total

1.  Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes.

Authors:  Nuno J Lamas; Alejandro D Garcia; Laurent Roybon; Eun Ju Yang; Rita Sattler; Vernice J Lewis; Yoon A Kim; C Alan Kachel; Jeffrey D Rothstein; Serge Przedborski; Hynek Wichterle; Christopher E Henderson
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

Review 2.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

3.  Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

Authors:  Junchao Tong; Lee-Cyn Ang; Belinda Williams; Yoshiaki Furukawa; Paul Fitzmaurice; Mark Guttman; Isabelle Boileau; Oleh Hornykiewicz; Stephen J Kish
Journal:  Neurobiol Dis       Date:  2015-06-21       Impact factor: 5.996

4.  Distribution of glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes in the rat brain. I. Forebrain.

Authors:  M Kálmán; F Hajós
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

5.  Histological-MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis.

Authors:  Mark D Meadowcroft; Nathan J Mutic; Don C Bigler; Jian-Li Wang; Zachary Simmons; James R Connor; Qing X Yang
Journal:  J Magn Reson Imaging       Date:  2014-02-26       Impact factor: 4.813

Review 6.  The neuropathological signature of bulbar-onset ALS: A systematic review.

Authors:  S Shellikeri; V Karthikeyan; R Martino; S E Black; L Zinman; J Keith; Y Yunusova
Journal:  Neurosci Biobehav Rev       Date:  2017-02-02       Impact factor: 8.989

7.  A unique pattern of astrocytosis in the primary motor area in amyotrophic lateral sclerosis.

Authors:  S Murayama; K Inoue; H Kawakami; T W Bouldin; K Suzuki
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Neurofilament and glial alterations in the cerebral cortex in amyotrophic lateral sclerosis.

Authors:  D Troost; P A Sillevis Smitt; J M de Jong; D F Swaab
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Immunocytochemical and ultrastructural studies of the motor cortex in amyotrophic lateral sclerosis.

Authors:  S Sasaki; S Maruyama
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model.

Authors:  Cátia Gomes; Carolina Cunha; Filipe Nascimento; Joaquim A Ribeiro; Ana Rita Vaz; Dora Brites
Journal:  Mol Neurobiol       Date:  2018-07-11       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.